govt.fyi
Back to SB 773
Oklahoma Legislature· SB 773Veto override message received

An act relating to pharmacy benefit managers, the official text

Shown verbatim: the complete text as captured from the official PDF posted by the Oklahoma Legislature, fetched 2026-07-23. Page and line markers are part of the official record; nothing is edited or removed. The official bill page.
1                        STATE OF OKLAHOMA

1

2                 1st Session of the 60th Legislature (2025)

2

3 SENATE BILL 773                 By: Gollihare
3

4

4

5

5

6                        AS INTRODUCED

6

7   An Act relating to pharmacy benefit managers;

7   amending 36 O.S. 2021, Sections 6960, as last amended

8   by Section 1, Chapter 306, O.S.L. 2024, 6962, as last

8   amended by Section 2, Chapter 306, O.S.L. 2024, and

9   6965, as last amended by Section 3, Chapter 306,

9   O.S.L. 2024 (36 O.S. Supp. 2024, Sections 6960, 6962,

10  and 6965), which relate to definitions, compliance

10  review, and power and authority to investigate,

11  examine, and enforce; modifying definitions;

11  prohibiting certain circumstances; requiring

12  nonpayment under providing venue for certain court

12  proceeding; allowing Attorney General to obtain

13  certain information; extending certain duties; and

13  providing an effective date.

14

14

15

15

16 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
16

17  SECTION 1.     AMENDATORY  36 O.S. 2021, Section 6960, as

17

18 last amended by Section 1, Chapter 306, O.S.L. 2024 (36 O.S. Supp.
18

19 2024, Section 6960), is amended to read as follows:
19

20  Section 6960. A. For purposes of the Patient's Right to

20

21 Pharmacy Choice Act:
21

22  1. "Covered entity" means a nonprofit hospital or medical

22

23 service organization, for-profit hospital or medical service
23

24 organization, insurer, health benefit plan, health maintenance
24

    Req. No. 697                                              Page 1
1 organization, health program administered by the state in the
1

2 capacity of providing health coverage, or an employer, labor union,
2

3 or other group of persons that provides health coverage to persons
3

4 in this state. This term does not include a health plan that
4

5 provides coverage only for accidental injury, specified disease,
5

6 hospital indemnity, disability income, or other limited benefit
6

7 health insurance policies and contracts that do not include
7

8 prescription drug coverage;
8

9   2. "Health insurer" means any corporation, association, benefit

9

10 society, exchange, partnership or individual licensed by the
10

11 Oklahoma Insurance Code;
11

12  3. "Health insurer payor" means a health insurance company,

12

13 health maintenance organization, union, hospital and medical
13

14 services organization or any entity providing or administering a
14

15 self-funded health benefit plan;
15

16  4. "Mail-order pharmacy" means a pharmacy licensed by this

16

17 state that primarily dispenses and delivers covered drugs via common
17

18 carrier;
18

19  5. "Pharmacy benefits manager" or "PBM" means a person,

19

20 business, or other entity that performs pharmacy benefits
20

21 management. The term shall include a person or entity acting on
21

22 behalf of a PBM in a contractual or employment relationship in the
22

23 performance of pharmacy benefits management for a managed care
23

24 company, nonprofit hospital, medical service organization, insurance
24

    Req. No. 697                                               Page 2
1 company, third-party payor or a health program administered by a
1

2 department of this state;
2

3   6. "Pharmacy benefits management" means a service provided to

3

4 covered entities to facilitate the provisions of prescription drug
4

5 benefits to covered individuals within the state, including, but not
5

6 limited to, negotiating pricing and other terms with drug
6

7 manufacturers and providers. Pharmacy benefits management may
7

8 include any or all of the following services:
8

9   a. claims processing, retail network management, and

9

10                payment of claims to pharmacies for prescription drugs

10

11                dispensed to covered individuals,

11

12  b. administration or management of pharmacy discount

12

13                cards or programs,

13

14  c. clinical formulary development and management

14

15                services, or

15

16  d. c. rebate contracting and administration;

16

17  7. "Provider" means a pharmacy, as defined in Section 353.1 of

17

18 Title 59 of the Oklahoma Statutes or an agent or representative of a
18

19 pharmacy;
19

20  8. "Retail pharmacy network" means retail pharmacy providers

20

21 contracted with a PBM in which the pharmacy primarily fills and
21

22 sells prescriptions via a retail, storefront location;
22

23

23

24

24

    Req. No. 697                                             Page 3
1   9. "Rural service area" means a five-digit ZIP code in which

1

2 the population density is less than one thousand (1,000) individuals
2

3 per square mile;
3

4   10. "Spread pricing" means a prescription drug pricing model

4

5 utilized by a pharmacy benefits manager in which the PBM charges a
5

6 health benefit plan a contracted price for prescription drugs that
6

7 differs from the amount the PBM directly or indirectly pays the
7

8 pharmacy or pharmacist for providing pharmacy services;
8

9   11. "Suburban service area" means a five-digit ZIP code in

9

10 which the population density is between one thousand (1,000) and
10

11 three thousand (3,000) individuals per square mile; and
11

12  12. "Urban service area" means a five-digit ZIP code in which

12

13 the population density is greater than three thousand (3,000)
13

14 individuals per square mile.
14

15  B. Nothing in the definitions of pharmacy benefits manager or

15

16 pharmacy benefits management as such terms are defined in the
16

17 Patient's Right to Pharmacy Choice Act, the Pharmacy Audit Integrity
17

18 Act, or Sections 357 through 360 of Title 59 of the Oklahoma
18

19 Statutes shall be construed to deem the following entities to be a
19

20 pharmacy benefits manager:
20

21  1. An employer of its own self-funded health benefit plan,

21

22 except, to the extent permitted by applicable law, where the
22

23 employer without the utilization of a third party and unrelated to
23

24 the employer's own pharmacy:
24

    Req. No. 697                                            Page 4
1   a. negotiates directly with drug manufacturers,

1

2   b. processes claims on behalf of its members, or

2

3   c. manages its own retail network of pharmacies; or

3

4   2. A pharmacy that provides a patient with a discount card or

4

5 program that is for exclusive use at the pharmacy offering the
5

6 discount.
6

7   SECTION 2.    AMENDATORY         36 O.S. 2021, Section 6962, as

7

8 last amended by Section 2, Chapter 306, O.S.L. 2024 (36 O.S. Supp.
8

9 2024, Section 6962), is amended to read as follows:
9

10  Section 6962. A. The Attorney General shall review and approve

10

11 retail pharmacy network access for all pharmacy benefits managers
11

12 (PBMs) to ensure compliance with Section 6961 of this title.
12

13  B. A PBM, or an agent of a PBM, shall not:

13

14  1. Cause or knowingly permit the use of advertisement,

14

15 promotion, solicitation, representation, proposal or offer that is
15

16 untrue, deceptive or misleading;
16

17  2. Charge a pharmacist or pharmacy a fee related to the

17

18 adjudication of a claim including without limitation a fee for:
18

19  a. the submission of a claim,

19

20  b. enrollment or participation in a retail pharmacy

20

21                network, or

21

22  c. the development or management of claims processing

22

23                services or claims payment services related to

23

24                participation in a retail pharmacy network;

24

    Req. No. 697                                               Page 5
1   3. Reimburse a pharmacy or pharmacist in the state an amount

1

2 less than the amount that the PBM reimburses a pharmacy owned by or
2

3 under common ownership with a PBM for providing the same covered
3

4 services. The reimbursement amount paid to the pharmacy shall be
4

5 equal to the reimbursement amount calculated on a per-unit basis
5

6 using the same generic product identifier or generic code number
6

7 paid to the PBM-owned or PBM-affiliated pharmacy;
7

8   4. Deny a provider the opportunity to participate in any

8

9 pharmacy network at preferred participation status if the provider
9

10 is willing to accept the terms and conditions that the PBM has
10

11 established for other providers as a condition of preferred network
11

12 participation status;
12

13  5. Deny, limit or terminate a provider's contract based on

13

14 employment status of any employee who has an active license to
14

15 dispense, despite probation status, with the State Board of
15

16 Pharmacy;
16

17  6. Retroactively deny or reduce reimbursement for a covered

17

18 service claim after returning a paid claim response as part of the
18

19 adjudication of the claim, unless:
19

20  a. the original claim was submitted fraudulently, or

20

21  b. to correct errors identified in an audit, so long as

21

22                the audit was conducted in compliance with Sections

22

23                356.2 and 356.3 of Title 59 of the Oklahoma Statutes;

23

24

24

    Req. No. 697                                                Page 6
1   7. Fail to make any payment due to a pharmacy or pharmacist for

1

2 covered services properly rendered in the event a PBM terminates a
2

3 provider from a pharmacy benefits manager network;
3

4   8. Fail to make any payment due to a pharmacy or pharmacist for

4

5 covered services properly rendered in the event a PBM terminates its
5

6 contract with a plan sponsor or insurer;
6

7   9. Conduct or practice spread pricing, as defined in Section

7

8 6960 of this title, in this state; or
8

9   9. 10. Charge a pharmacist or pharmacy a fee related to

9

10 participation in a retail pharmacy network including but not limited
10

11 to the following:
11

12  a. an application fee,

12

13  b. an enrollment or participation fee,

13

14  c. a credentialing or re-credentialing fee,

14

15  d. a change of ownership fee, or

15

16  e. a fee for the development or management of claims

16

17                processing services or claims payment services.

17

18  C. The prohibitions under this section shall apply to contracts

18

19 between pharmacy benefits managers and providers for participation
19

20 in retail pharmacy networks.
20

21  1. A PBM contract shall:

21

22  a. not restrict, directly or indirectly, any pharmacy

22

23                that dispenses a prescription drug from informing, or

23

24                penalize such pharmacy for informing, an individual of

24

    Req. No. 697                                      Page 7
1                 any differential between the individual's out-of-

1

2                 pocket cost or coverage with respect to acquisition of

2

3                 the drug and the amount an individual would pay to

3

4                 purchase the drug directly, and

4

5   b. ensure that any entity that provides pharmacy benefits

5

6                 management services under a contract with any such

6

7                 health plan or health insurance coverage does not,

7

8                 with respect to such plan or coverage, restrict,

8

9                 directly or indirectly, a pharmacy that dispenses a

9

10                prescription drug from informing, or penalize such

10

11                pharmacy for informing, a covered individual of any

11

12                differential between the individual's out-of-pocket

12

13                cost under the plan or coverage with respect to

13

14                acquisition of the drug and the amount an individual

14

15                would pay for acquisition of the drug without using

15

16                any health plan or health insurance coverage.

16

17  2. A pharmacy benefits manager's contract with a provider shall

17

18 not prohibit, restrict, or limit disclosure of information or
18

19 documents to the Attorney General, law enforcement or state and
19

20 federal governmental officials investigating or examining a
20

21 complaint or conducting a review of a pharmacy benefits manager's
21

22 compliance with the requirements under the Patient's Right to
22

23 Pharmacy Choice Act, the Pharmacy Audit Integrity Act, and Sections
23

24 357 through 360 of Title 59 of the Oklahoma Statutes.
24

    Req. No. 697                                                 Page 8
1   D. A pharmacy benefits manager shall:

1

2   1. Establish and maintain an electronic claim inquiry

2

3 processing system using the National Council for Prescription Drug
3

4 Programs' current standards to communicate information to pharmacies
4

5 submitting claim inquiries;
5

6   2. Fully disclose to insurers, self-funded employers, unions or

6

7 other PBM clients the existence of the respective aggregate
7

8 prescription drug discounts, rebates received from drug
8

9 manufacturers and pharmacy audit recoupments;
9

10  3. Provide the Attorney General, insurers, self-funded employer

10

11 plans and unions unrestricted audit rights of and access to the
11

12 respective PBM pharmaceutical manufacturer and provider contracts,
12

13 plan utilization data, plan pricing data, pharmacy utilization data
13

14 and pharmacy pricing data;
14

15  4. Maintain, for no less than three (3) years, documentation of

15

16 all network development activities including but not limited to
16

17 contract negotiations and any denials to providers to join networks.
17

18 This documentation shall be made available to the Attorney General
18

19 upon request; and
19

20  5. Report to the Attorney General, on a quarterly basis for

20

21 each health insurer payor, on the following information:
21

22  a. the aggregate amount of rebates received by the PBM,

22

23  b. the aggregate amount of rebates distributed to the

23

24                appropriate health insurer payor,

24

    Req. No. 697                                               Page 9
1   c. the aggregate amount of rebates passed on to the

1

2                 enrollees of each health insurer payor at the point of

2

3                 sale that reduced the applicable deductible,

3

4                 copayment, coinsure or other cost sharing amount of

4

5                 the enrollee,

5

6   d. the individual and aggregate amount paid by the health

6

7                 insurer payor to the PBM for pharmacy services

7

8                 itemized by pharmacy, drug product and service

8

9                 provided, and

9

10  e. the individual and aggregate amount a PBM paid a

10

11                provider for pharmacy services itemized by pharmacy,

11

12                drug product and service provided.

12

13  E. Nothing in the Patient's Right to Pharmacy Choice Act shall

13

14 prohibit the Attorney General from requesting and obtaining detailed
14

15 data, including raw data, in response to the information provided by
15

16 a PBM in the quarterly reports required by this section. The
16

17 Attorney General may alter the frequency of the reports required by
17

18 this section at his or her sole discretion.
18

19  F. The Attorney General may promulgate rules to implement the

19

20 provisions of the Patient's Right to Pharmacy Choice Act, the
20

21 Pharmacy Audit Integrity Act, and Sections 357 through 360 of Title
21

22 59 of the Oklahoma Statutes.
22

23

23

24

24

    Req. No. 697                                                Page 10
1   SECTION 3.        AMENDATORY  36 O.S. 2021, Section 6965, as

1

2 last amended by Section 3, Chapter 306, O.S.L. 2024 (36 O.S. Supp.
2

3 2024, Section 6965), is amended to read as follows:
3

4   Section 6965. A. The Attorney General shall have power and

4

5 authority to examine and investigate the affairs of every pharmacy
5

6 benefits manager (PBM) engaged in pharmacy benefits management in
6

7 this state in order to determine whether such entity is in
7

8 compliance with the Patient's Right to Pharmacy Choice Act, the
8

9 Pharmacy Audit Integrity Act, and Sections 357 through 360 of Title
9

10 59 of the Oklahoma Statutes.
10

11  B. The Attorney General shall have the power and authority to

11

12 subpoena witnesses and records, whether prior to or during an
12

13 investigation or prosecution of a complaint, from any relevant
13

14 entity or persons to ensure compliance with the Patient's Right to
14

15 Pharmacy Choice Act, the Pharmacy Audit Integrity Act, and Sections
15

16 357 through 360 of Title 59 of the Oklahoma Statutes.
16

17  C. All PBM files and records shall be subject to examination by

17

18 the Attorney General or by duly appointed designees. The Attorney
18

19 General, authorized employees and examiners shall have access to any
19

20 of a PBM's files and records that may relate to a particular
20

21 complaint under investigation or to an inquiry or examination by the
21

22 Attorney General.
22

23  D. Every officer, director, employee or agent of the PBM, upon

23

24 receipt of any inquiry from the Attorney General, shall, within
24

    Req. No. 697                                              Page 11
1 twenty (20) days from the date the inquiry is sent, furnish the
1

2 Attorney General with an adequate response to the inquiry.
2

3   E. When making an examination under this section, the Attorney

3

4 General may retain subject matter experts, attorneys, appraisers,
4

5 independent actuaries, independent certified public accountants or
5

6 an accounting firm or individual holding a permit to practice public
6

7 accounting, certified financial examiners or other professionals and
7

8 specialists as examiners, the cost of which shall be borne by the
8

9 PBM that is the subject of the examination.
9

10  F. 1. Protected health information (PHI) held by a PBM shall

10

11 be provided at the request of the Attorney General for the purpose
11

12 of conducting investigations into potential violations of state laws
12

13 and regulations related to the PBM. Disclosure of protected health
13

14 information shall be limited to the extent necessary for the
14

15 investigation and enforcement of state law.
15

16  2. All disclosures of protected health information shall be

16

17 made in compliance with all applicable federal and state privacy
17

18 laws, including the Health Insurance Portability and Accountability
18

19 Act of 1996 (HIPAA), and other relevant laws protecting the privacy
19

20 and confidentiality of health information.
20

21  3. Any protected health information obtained for an

21

22 investigation shall be handled and maintained per applicable federal
22

23 and state privacy laws and regulations, including HIPAA.
23

24

24

    Req. No. 697                                              Page 12
1   4. Unauthorized disclosure of protected health information

1

2 obtained during an investigation is strictly prohibited and subject
2

3 to legal penalties.
3

4   G. 1. If the Attorney General, after notice and opportunity

4

5 for hearing, finds that any PBM operating within this state has not
5

6 fully cooperated with an investigation or inquiry conducted by the
6

7 Attorney General related to compliance with the Patient's Right to
7

8 Pharmacy Choice Act, the Pharmacy Audit Integrity Act, and Sections
8

9 357 through 360 of Title 59 of the Oklahoma Statutes, the Attorney
9

10 General may instruct the Insurance Commissioner that the PBM be
10

11 censured or his or her license be suspended or revoked. If the
11

12 Attorney General makes such instruction, the Commissioner shall
12

13 enforce the instructed action within thirty (30) days.
13

14  2. In addition to or in lieu of any censure, suspension, or

14

15 revocation by the Commissioner, the Attorney General may levy a
15

16 civil or administrative fine not less than One Hundred Dollars
16

17 ($100.00) and not greater than Ten Thousand Dollars ($10,000.00) for
17

18 each violation of this subsection and assess any other penalty or
18

19 remedy authorized by this act. For purposes of this section, each
19

20 day a PBM fails to comply with an investigation or inquiry may be
20

21 considered a separate violation.
21

22  H. The proper venue to compel compliance with a subpoena of a

22

23 person or entity under this section shall be in the Oklahoma County
23

24 District Court.
24

    Req. No. 697                                           Page 13
1   I. No provision of this state's law shall be construed to

1

2 prohibit the Attorney General from obtaining any information or
2

3 documentation pertaining to prescription drug transactions
3

4 including, but not limited to, data, statements, testimonies,
4

5 contracts, communications, provider manuals, or any other
5

6 documentation or materials, whether related to discount programs,
6

7 loyalty programs, or otherwise. The duty to provide cooperation as
7

8 set forth in this section shall extend to all PBMs, insurers,
8

9 auditors, employers, vendors, or any other individual or entity
9

10 acting on behalf of or in collaboration with a PBM.
10

11  SECTION 4. This act shall become effective November 1, 2025.

11

12

12

13  60-1-697      CAD  1/19/2025 5:43:03 AM

13

14

14

15

15

16

16

17

17

18

18

19

19

20

20

21

21

22

22

23

23

24

24

    Req. No. 697                                              Page 14
Every fact on this page links to its source, starting with the official bill record.